参考文献/References:
[1]MCCRINDLE B W,ROWLEY A H,NEWBURGER J W,et al.Diagnosis,treatment,and long-term management of kawasaki disease:A scientific statement for health professionals from the american heart association[J].Circulation,2017,135(17):e927-e999.
[2]AE R,SHIBATA Y,KOBAYASHI T,et al.Differences in sensitivity between the japanese and Z score criteria for detecting coronary artery abnormalities resulting from kawasaki disease[J].Pediatr Cardiol,2023,44(1):153-160.
[3]PAN Y,JIAO F Y.Systematic comparison of Kawasaki disease Z-score formulas:Enhancing diagnostic accuracy and clinical applicability across populations[J].World J Clin Pediatr,2025,14(1):102254.
[4]SI X,HOU C,WANG H,et al.Comparison of six Z-score formulas based on echocardiography for coronary artery lesions in Kawasaki disease[J].Int J Cardiol,2024,409:132102.
[5]TUAN S H,CHUNG J H,CHEN G B,et al.When two Z-scores meet-analysis of exercise capacity of children and adolescents with Kawasaki disease by a new Z-score model of coronary artery and a new Z-score evaluating peak oxygen consumption:Coronary artery Z-score and peakVO2 Z-score in KD[J].Ital J Pediatr,2023,49(1):129.
[6]LI X,CHEN Y,TANG Y,et al.Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children:A meta-analysis of 4442 cases[J].Eur J Pediatr,2018,177(8):1279-1292.
[7]WU Y,WANG S,ZHOU Y,et al.Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease[J].PLoS One,2023,18(10):e0292653.
[8]吴晓云,钱永如,田杰,等.川崎病并发冠状动脉损害的危险因素及预后分析[J].第三军医大学学报,2002,24(4):476-478.
[9]王永,蒋佳颖,邓燕,等.基于Z值回归模型诊断儿童冠状动脉病变的研究[J].中国当代儿科杂志,2025,27(2):176-183.
[10]夏焙,许娜,何学智,等.儿童超声心动图冠状动脉正常参考值及临床意义[J].中华医学超声杂志(电子版),2013,10(1):42-51.
[11]仲玉强.小儿川崎病心率变异性指标与肌钙蛋白Ⅰ和氨基末端脑钠肽前体相关性分析[J].中国实用儿科杂志,2016,31(8):615-618.
[12]翟蒙藏,张文宗,张鸣.保元逐瘀护心汤对老年冠心病合并高血压患者血压、心功能及Salusin-β、TNF-α、CRP水平的影响[J].陕西中医,2024,45(4):494-497.
[13]董春华.儿童呼吸道感染血清CRP和ESR的变化及临床意义[J].实验与检验医学,2009,27(5):572,588.
[14]蔡敏一,赵德强,于宏梅,等.老年冠心病患者血清脂联素、生长素释放肽水平与血小板聚集率及主要不良心脏事件相关性分析[J].陕西医学杂志,2024,53(7):931-935.
[15]谌登珍,马强.血清补体C1q、C3与中性粒细胞胞浆抗体相关性血管炎患者临床特征、病理类型及预后相关性研究[J].陕西医学杂志,2023,52(1):105-109.
[16]张志辉,束永兵.益气养血方联合促红素治疗糖尿病肾病腹膜透析患者肾性贫血临床观察[J].陕西中医,2024,45(5):630-633.
[17]户富栋,王祥,朱争凤,等.血电解质和白蛋白浓度与冠状动脉病变严重性的关系[J].临床心血管病杂志,2011,27(2):126-130.
[18]SHUAI S,ZHANG H,ZHANG R,et al.Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki disease:A retrospective cohort study[J].J Pediatr (Rio J),2023,99(4):406-412.
[19]FOY B H,SUNDT T M,CARLSON J C T,et al.Human acute inflammatory recovery is defined by co-regulatory dynamics of white blood cell and platelet populations[J].Nat Commun,2022,13(1):4705.
[20]赵浩南,陈纪宏,白朝辉,等.人血白蛋白对肝硬化肝性脑病患者氧化应激反应影响[J].临床军医杂志,2024,52(9):965-967.
[21]陈伟翔,殷人麟,凌琳,等.C反应蛋白/白蛋白比值与不稳定型心绞痛患者冠状动脉侧支循环形成的相关性研究[J].中国全科医学,2023,26(27):3430-3434.
[22]许艳鹏,赵京,刘彦平.基于C反应蛋白表达预测川崎病并发冠状动脉损伤患儿风险的列线图模型构建[J].岭南心血管病杂志,2023,29(2):156-161,179.
[23]HEUSCH G.Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia:Benefit from selective bradycardic agents[J].Br J Pharmacol,2008,153(8):1589-1601.
[24]GIANNOGLOU G D,CHATZIZISIS Y S,ZAMBOULIS C,et al.Elevated heart rate and atherosclerosis:An overview of the pathogenetic mechanisms[J].Int J Cardiol,2008,126(3):302-312.
[25]王帧,张帅,许哲.川崎病合并冠状动脉病变患者血清Ang-1、YKL-40水平与凝血功能、炎症反应的相关性[J].中国动脉硬化杂志,2024,32(5):424-428.
[26]阮瑜,赵晓东.川崎病并发症临床分析[J].中华实用儿科临床杂志,2014,29(1):37-40.
[27]CAI J,TANG M,SHUAI S,et al.The role of red blood cell distribution width in predicting coronary artery lesions in pediatric patients with kawasaki disease[J].Front Cardiovasc Med,2023,10:1014890.
[28]HANAWA Y,MURASAKI W,NAMBA H,et al.Red blood cell distribution width predicts coronary artery lesions in Kawasaki disease:Insights from a Japanese cohort[J].Pediatr Rheumatol Online J,2025,23(1):31.
[29]JIN F,CHANG X,WANG X,et al.Relationship between red blood cell-related indices and coronary artery calcification[J].Postgrad Med J,2023,99(1167):4-10.
[30]李淑华,于明华,张丽,等.抗中性粒细胞抗体对川崎病诊断价值研究[J].中国实用儿科杂志,2008,23(2):122-124.
相似文献/References:
[1]孙生健,牛玉军.256层iCTA在心肌病合并冠状动脉狭窄及左心功能评估中的价值研究[J].陕西医学杂志,2019,(5):620.
SUN Shengjian,NIU Yujun..A 256layer iCTA study on cardiomyopathy with coronary artery stenosis and left heart function[J].,2019,(12):620.
[2]杨荣荣,马佳娜△.超声心动图和心肌酶学检测在患儿川崎病合并冠状动脉病变诊断中的应用*[J].陕西医学杂志,2020,49(10):1259.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.015]
YANG Rongrong,MA Jiana..Application value analysis of echocardiography and myocardial enzyme indexes in children with Kawasaki disease complicated with coronary artery disease[J].,2020,49(12):1259.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.015]
[3]孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
SUN Chunhui,LE Yuan.Changes and clinical significance of prealbumin,cystatin C and four parameters of platelet in Kawasaki disease children with coronary arterial lesions[J].,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
[4]严晓华,王 娜,马 娟,等.阿托伐他汀对小鼠川崎病的治疗作用及机制研究[J].陕西医学杂志,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
YAN Xiaohua,WANG Na,MA Juan,et al.Therapeutic effect and mechanism of atorvastatin on Kawasaki disease mice[J].,2022,51(12):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
[5]寇志军,李 静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
KOU Zhijun,LI Jing,MA Hengman,et al.Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease[J].,2022,51(12):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
[6]赵 萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,(2):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
ZHAO Meng,YANG Yitong,LI Hanwen,et al.Research progress on relationship between gut microbiota and Kawasaki disease[J].,2024,(12):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
[7]杨 敏,刘 鑫.血清可溶性肿瘤坏死因子受体Ⅱ/Ⅰ比值、白细胞介素-17联合心电图诊断川崎病患儿急性期冠状动脉损伤的价值[J].陕西医学杂志,2025,54(3):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
YANG Min,LIU Xin.Value of serum sTNFR Ⅱ/Ⅰ,IL-17 combined with ECG in diagnosis of coronary artery injury in children with Kawasaki disease in acute phase[J].,2025,54(12):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
[8]冯千伟,王晓青,焦丽华,等.川崎病患儿血清血管生成素样蛋白8、生长分化因子-15水平与并发冠状动脉病变关系研究[J].陕西医学杂志,2025,54(3):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
FENG Qianwei,WANG Xiaoqing,JIAO Lihua,et al.Relationship between serum ANGPTL8,GDF-15 levels with concurrent coronary artery disease in children with Kawasaki disease[J].,2025,54(12):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
[9]黄小琼,陈相才,冯维,等.治疗前ALB/ESR、LDH联合SII对川崎病患儿常规剂量IVIG应答不良的预测价值[J].陕西医学杂志,2025,54(9):1243.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.016]
HUANG Xiaoqiong,CHEN Xiangcai,FENG Wei,et al.Predictive value of ALB/ESR and LDH combined with SII before treatment for poor response to conventional dose of IVIG in children with Kawasaki disease[J].,2025,54(12):1243.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.016]